Company Analysis

BillionToOne, Inc. (BLLN)

Nasdaq: BLLN · Services-Medical Laboratories · Menlo Park, CA · filing with the SEC since 2025
Grade6.8
◀ Past 6.7● Present 7.0▶ Future 6.7
3 est.

Filings

35 filings since 2017 beside 146 insider forms · Non-accelerated filer and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 21, 2026.

Filings a yearinsider forms included
43138
20252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Mar 4, 2026.SEC letters: 2 in the last 36 months, the newest Aug 26, 2025.
Insider forms 146

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 SCHEDULE 13D/A Activist holder update, amended
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 29, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Jun 23, 2026
Jun 16, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Jun 10, 2026
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 21, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 21, 2026 DEFA14A Extra proxy material
Apr 21, 2026 DEF 14A Proxy statement Jun 10, 2026
Mar 11, 2026 10-K Annual report Dec 31, 2025
Mar 4, 2026 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
Feb 17, 2026 SCHEDULE 13G Large holder notice
Feb 17, 2026 SCHEDULE 13G Large holder notice
Feb 13, 2026 SCHEDULE 13G Large holder notice
Jan 20, 2026 SCHEDULE 13D Activist holder notice
Jan 12, 2026 8-K items 2.02, 7.01 Results released; Investor disclosure (Regulation FD) · Current report
Dec 10, 2025 10-Q Quarterly report Sep 30, 2025
Dec 9, 2025 8-K items 2.02, 5.02, 9.01 Results released; Officer or director change · Current report
Nov 10, 2025 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report Nov 7, 2025
Nov 6, 2025 424B4 Offering prospectus
Nov 6, 2025 S-8 Employee stock plan registration
Nov 5, 2025 CERT Exchange listing certification
Nov 3, 2025 8-A12B Class of securities registered for listing
Oct 17, 2025 S-1/A Listing registration, amended
Oct 7, 2025 S-1 Listing registration
Sep 17, 2025 DRSLTR Form DRSLTR
Sep 17, 2025 DRS/A Draft registration, confidential, amended
Aug 26, 2025 UPLOAD SEC comment letter
Aug 11, 2025 DRSLTR Form DRSLTR
Aug 11, 2025 DRS/A Draft registration, confidential, amended
Jul 17, 2025 UPLOAD SEC comment letter
Jun 20, 2025 DRS Draft registration, confidential

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BLLN · research, not advice